BOSTON, July 16, 2026 /PRNewswire/ — HoneyNaps, an AI-based sleep medicine company, today announced that SOMNUM V3.0, its AI diagnosis software for polysomnography (PSG) analysis, has received U.S. Food and Drug Administration (FDA) clearance under clearance number K253390.
The LightningWire system is designed to support transseptal access in procedures such as atrial fibrillation ablation, left atrial appendage closure and transcatheter mitral interventions.
The disease is projected to become the fifth leading cause of death by 2040 if diagnosis and treatment rates do not improve
Learn how mechanical stretching helped lab-grown vessels sprout and redirect new capillaries, a step toward keeping engineered tissues alive.
Newronika announced today that it secured CE mark for its latest adaptive deep brain stimulation (aDBS) system.
HistoSonics announced today that it received CE mark approval for its Edison non-invasive histotripsy technology platform.
Claria Medical announced today that it received FDA de novo authorization for its Claria system for minimally invasive hysterectomies.
Abbott (NYSE:ABT) announced today that the FDA approved the longer length (76 mm) Esprit BTK drug-eluting scaffold system.
SAN DIEGO, July 7, 2026 /PRNewswire/ — CliniComp, a pioneer in high-performing, reliable, electronic health record (EHR) solutions, announced FDA 510(k) clearance of its PACS (Picture Archiving and Communication System) Viewer as a Medical Image Management and Processing System (MIMPS).
To develop new and better peptides, the short amino acid strings behind medicines like GLP-1 drugs, researchers have used AI to generate candidates and to predict their properties.